Market Rumors Grow On Potential GSK Purchase Of Nanjing MeiRui Pharma For Urology Expansion In China
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI- Market rumors are growing that GlaxoSmithKline will add on to its urology franchise in China with a local acquisition